Haleon PLC Sponsored ADR (HLN) has released an update.
Haleon plc, a leading global consumer health company, has announced that as of March 31, 2024, it has 9,132,301,104 ordinary shares with voting rights in circulation, with none held in Treasury. This share count is pivotal for shareholders to determine the need for notifications of interest changes under the FCA’s rules. The company, which houses well-known brands like Advil and Centrum, emphasizes its commitment to enhancing everyday health.
For further insights into HLN stock, check out TipRanks’ Stock Analysis page.
